520 related articles for article (PubMed ID: 20802331)
21. [The rise of resistant gram-negative bacteria].
Kuijper EJ; van Dissel JT
Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590
[TBL] [Abstract][Full Text] [Related]
22. Impact of a hospital-wide antimicrobial formulary intervention on the incidence of multidrug-resistant gram-negative bacteria.
Furtado GH; Perdiz LB; Santana IL; Camargo MM; Parreira FC; Angelieri DB; Medeiros EA
Am J Infect Control; 2008 Nov; 36(9):661-4. PubMed ID: 18834728
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of bacteraemia in Hamad general hospital, Qatar: a one year hospital-based study.
Khan FY; Elshafie SS; Almaslamani M; Abu-Khattab M; El Hiday AH; Errayes M; Almaslamani E
Travel Med Infect Dis; 2010 Nov; 8(6):377-87. PubMed ID: 21074495
[TBL] [Abstract][Full Text] [Related]
24. In vitro evaluation of a new cefixime-clavulanic acid combination for gram-negative bacteria.
Rawat D; Hasan AS; Capoor MR; Sarma S; Nair D; Deb M; Pillai P; Aggarwal P
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):131-9. PubMed ID: 19323045
[TBL] [Abstract][Full Text] [Related]
25. Epidemiologic study of nosocomial bacterial infection of pediatric patients at BMA Medical College and Vajira Hospital.
Tantracheewathorn T; Vititpatarapak N; Phumisantiphong U
J Med Assoc Thai; 2007 Feb; 90(2):258-65. PubMed ID: 17375629
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
[TBL] [Abstract][Full Text] [Related]
27. Combination antibiotic therapy for empiric and definitive treatment of gram-negative infections: insights from the Society of Infectious Diseases Pharmacists.
Boyd N; Nailor MD
Pharmacotherapy; 2011 Nov; 31(11):1073-84. PubMed ID: 22026395
[TBL] [Abstract][Full Text] [Related]
28. Frequency of Gram-negative bacterial pathogens in bloodstream infections and their resistance to antibiotics in the Czech Republic.
Cermák P; Kolár M; Látal T
Int J Antimicrob Agents; 2004 Apr; 23(4):401-4. PubMed ID: 15081092
[TBL] [Abstract][Full Text] [Related]
29. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.
Sánchez A; Gattarello S; Rello J
Semin Respir Crit Care Med; 2011 Apr; 32(2):151-8. PubMed ID: 21506051
[TBL] [Abstract][Full Text] [Related]
30. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities.
Wisplinghoff H; Seifert H; Tallent SM; Bischoff T; Wenzel RP; Edmond MB
Pediatr Infect Dis J; 2003 Aug; 22(8):686-91. PubMed ID: 12913767
[TBL] [Abstract][Full Text] [Related]
31. Trends in antimicrobial resistance in health care-associated pathogens and effect on treatment.
McDonald LC
Clin Infect Dis; 2006 Jan; 42 Suppl 2():S65-71. PubMed ID: 16355319
[TBL] [Abstract][Full Text] [Related]
32. What is in the pipeline for Gram-negative pathogens?
Talbot GH
Expert Rev Anti Infect Ther; 2008 Feb; 6(1):39-49. PubMed ID: 18251663
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004).
Bouchillon SK; Hoban DJ; Johnson BM; Johnson JL; Hsiung A; Dowzicky MJ;
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):173-9. PubMed ID: 16105561
[TBL] [Abstract][Full Text] [Related]
34. Strategies for managing today's infections.
Carmeli Y
Clin Microbiol Infect; 2008 Apr; 14 Suppl 3():22-31. PubMed ID: 18318876
[TBL] [Abstract][Full Text] [Related]
35. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849
[TBL] [Abstract][Full Text] [Related]
36. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
Nordmann P; Naas T; Fortineau N; Poirel L
Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
[TBL] [Abstract][Full Text] [Related]
37. The issue of antimicrobial resistance in human medicine.
Beović B
Int J Food Microbiol; 2006 Dec; 112(3):280-7. PubMed ID: 16815582
[TBL] [Abstract][Full Text] [Related]
38. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
39. [Changes in the incidence of multiresistant pathogens and its consequences in the intensive care unit].
Szucs O; Kristóf K; Darvas K; Csomós A
Orv Hetil; 2011 Sep; 152(37):1486-91. PubMed ID: 21893479
[TBL] [Abstract][Full Text] [Related]
40. Resistant gram-negative infections.
Fraimow H; Nahra R
Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
